Science Explorer Back to mapMap
Discussion
Researcher · Lublin Oncology Center · Poland

Łukasz Hajac

Łukasz Hajac publishes mostly in Oncology, Molecular Biology and Pulmonary and Respiratory Medicine, on topics such as Neuroendocrine Tumor Research Advances, HER2/EGFR in Cancer Research and Protein Kinase Regulation and GTPase Signaling.

OpenAlex
World rank
#3,493,355
of 7,710,434 ranked researchers
Rank in Poland
#23,847
of 100,960
Works
17
Citations
1.2k
Citations per work
69.2
h-index
4
i10-index 3Top 94% in Oncology
Łukasz Hajac

What does Łukasz Hajac research?

Łukasz Hajac's work is mostly in Medicine (55%), Biochemistry, Genetics and Molecular Biology (11%), Agricultural and Biological Sciences (4%).

Health Sciences: 9 works · 55.2% of their workMedicine: 9 works · 55.2% of their workOncology: 4 works · 25.5% of their workPulmonary and Respiratory Medicine: 2 works · 10.6% of their workSurgery: 2 works · 10.6% of their workEpidemiology: 1 works · 8.5% of their workEverything else: 5 works · 29.9% of their workLife Sciences: 3 works · 14.9% of their workBiochemistry, Genetics and Molecular Biology: 2 works · 10.6% of their workMolecular Biology: 2 works · 10.6% of their workAgricultural and Biological Sciences: 1 works · 4.3% of their workPlant Science: 1 works · 4.3% of their workTHEIR WORKŁukasz Hajac17works
Life Sciences15%Health Sciences55%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine955.2%
  2. Everything else529.9%
    1. Biochemistry, Genetics and Molecular Biology210.6%
    2. Agricultural and Biological Sciences14.3%
  1. 1Oncology26% of their works
  2. 2Molecular Biology11% of their works
  3. 3Pulmonary and Respiratory Medicine11% of their works
  4. 4Surgery11% of their works
  5. 5Epidemiology8% of their works
  6. 6Plant Science4% of their works

Research topics

Which keywords describe Łukasz Hajac's research?

The keywords of their largest research topics: Chemotherapy, Genetic Mutations, Immunotherapy, Neuroendocrine Tumors, Pancreatic Neuroendocrine Tumors, Breast Cancer, HER2 and ALK.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Chemotherapy73 topics
  2. Genetic Mutations62 topics
  3. Immunotherapy42 topics
  4. Neuroendocrine Tumors41 topic
  5. Pancreatic Neuroendocrine Tumors41 topic
  6. Breast Cancer31 topic
  7. HER231 topic
  8. ALK21 topic
  9. Cetuximab21 topic
  10. Chemotherapy-Induced Peripheral Neuropathy21 topic
  11. Genomic Profiles21 topic
  12. Immune Checkpoint Blockade21 topic
  13. KRAS Mutations21 topic
  14. Neuroblastoma21 topic
  15. PD-1 and PD-L121 topic
  16. Protein Kinases21 topic
  17. Ras Signaling21 topic
  18. Small-Cell Lung Cancer21 topic
  19. Taxanes21 topic

Where does Łukasz Hajac work?

Łukasz Hajac's main affiliation in the publication record is Lublin Oncology Center, Poland.

How many publications and citations does Łukasz Hajac have?

OpenAlex counts 17 works and 1,177 citations for Łukasz Hajac, an h-index of 4, ranking #3,493,355 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Łukasz Hajac. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.